Epigenetic mechanisms in Parkinson's disease
Authors:
- 1 February 2015
- journal article
- review article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 349 (1-2) , 3-9
Abstract
No abstract availableKeywords
Funding Information
- National Basic Research Program of China (2011CB707506)
- National Natural Science Foundation of China (NSFC) (81171205, 81371410)
- Shanghai Pujiang Program (11PJD019)
This publication has 74 references indexed in Scilit:
- Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's diseaseCell Death & Disease, 2013
- Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseNeuroscience, 2011
- Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degenerationNeuroToxicology, 2011
- Neuronal activity modifies the DNA methylation landscape in the adult brainNature Neuroscience, 2011
- α-Synuclein Sequesters Dnmt1 from the NucleusJournal of Biological Chemistry, 2011
- DNA methylation and memory formationNature Neuroscience, 2010
- Repression of α-synuclein expression and toxicity by microRNA-7Proceedings of the National Academy of Sciences, 2009
- Genomewide association study for susceptibility genes contributing to familial Parkinson diseaseHuman Genetics, 2008
- Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disordersCurrent Opinion in Pharmacology, 2008
- Chromatin Modifications and Their FunctionCell, 2007